High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China - Cao, Wei; Liu, Xiaosheng; Hong, Ke; Ma, Zhiyong; Zhang, Yuelun; Lin, Ling; Han, Yang; Xiong, Yong; Liu, Zhengyin; Ruan, Lianguo; Li, Taisheng (Frontiers in immunology, 2021)
Keywords: 28-day mortality; Adult; Aged; China - epidemiology; COVID-19; COVID-19 - blood; COVID-19 - drug therapy; COVID-19 - mortality; Disease-Free Survival; Female; Ferritins - blood; high-dose intravenous immunoglobulin; Humans; Immunoglobulins, Intravenous - administration & dosage; Immunology; immunomodulation; inflammatory markers; Interleukin-10 - blood; Interleukin-6 - blood; Male; Middle Aged; Retrospective Studies; SARS-CoV-2 - metabolism; Survival Rate; China; COVID-19; 28-day mortality; immunomodulation; inflammatory markers; high-dose intravenous immunoglobulin